Systemic Immune-Inflammation Response is Associated with Futile Recanalization After Endovascular Treatment.
Guojuan ChenAnxin WangXiaoli ZhangYuhao LiXue XiaXue TianJing LiZhongrong MiaoWei YuePublished in: Neurocritical care (2024)
Early SII elevation was associated with an increased risk of futile recanalization among patients with EVT. Our results indicated that therapeutic drug targeting hyperreactive immune-inflammation response might be helpful for reducing the incidence of futile recanalization.